IKS Health has completed an acquihire of ThinkDTM, an artificial intelligence (AI) native product, strategy and digital services company, and has appointed ThinkDTM founder Tij Bedi as Executive Vice President and General Manager, Patient Access and Innovation. The transaction brings Bedi and his team of AI technology experts into IKS Health’s patient access group under a mandate to implement agentic AI and product design expertise. The companies positioned the move as a strategic step to accelerate delivery of smarter, more accurate operations for providers and patients. The announcement was made on 31 March 2026. Bedi and his team will lead expansion, scaling and transformation of the patient access solutions portfolio, including patient scheduling, registration, demographic capture, insurance eligibility verification and prior authorisations. The newly expanded group will focus on building and scaling differentiated patient access solutions, strengthening platform capabilities and driving forward looking innovation to enhance outcomes for healthcare providers and patients. The work is intended to reduce administrative burdens and improve the end to end care journey. Senior leadership signalled that the addition of ThinkDTM’s specialists is critical as IKS Health increases investment in agentic AI and human in the loop expertise to support revenue optimisation and operational scale. IKS Health described the integration as a way to enable strategic partnerships that leverage innovative use of technology and create differentiated market opportunities. The company noted its Care Enablement platform integrates agentic AI workflows with human expertise to deliver smarter operations and financial sustainability. Founded in 2006, IKS Health said it is recognised by Black Book for AI driven RCM services, by KLAS for performance and client satisfaction and by Google Cloud with a DORA Award for augmenting human expertise with AI. The firm stated it partners with the largest health systems, physician groups and specialty practices across the United States and will leverage the new team to broaden market reach. Media and investor contact details were provided in the release.